Publications by authors named "Erling Haland"

Claim this Profile
E
Empirical antimicrobial therapy for bloodstream infections not compliant with guideline was associated with discordant therapy, which predicted poorer outcome even in a low resistance environment.
Kornelius Grøv, Erling Håland, Bjørn Waagsbø, Øyvind Salvesen, Jan Kristian Damås

Infect Dis (Lond)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAK1-inhibitors did not reduce disease burden in a Vκ*MYC model of multiple myeloma.
Erling Håland, Ingrid Nyhus Moen, Esten N Vandsemb, Kristian K Starheim

BMC Res Notes· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan.
Erling Håland, Ingrid Nyhus Moen, Elias Veidal, Hanne Hella, Kristine Misund

Oncotarget· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smac-mimetics reduce numbers and viability of human osteoclasts.
Ingrid Nyhus Moen, Marita Westhrin, Erling Håland, Markus Haug, Unni Nonstad

Cell Death Discov· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis